Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

IRIDEX CORP (IRIX)

$0.89 -3.38% NASDAQ: IRIX · 15-min delayed
  • MOUNTAIN VIEW, California
  • Public · NASDAQ: IRIX
  • 108 employees
$19.0MMarket cap
$52.7MRevenue · FY2026
-$4.4MNet income
108Employees
IRIXNASDAQ
1996IPO

About IRIDEX CORP

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2026
$52.7M
Net income
-$4.4M
Total assets
$29.2M
Market cap
$19.0M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2026

Financial statements

Balance sheet

Total assets
$29.2M
Current assets
$25.3M
Total liabilities
$24.2M
Current liabilities
$13.2M
Shareholders’ equity
$4.9M

Statements via Polygon.io (SEC filings)

NASDAQ: IRIX
$0.89 -3.38%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.88 $1.56

52-week range

Market cap
$19.0M
Shares outstanding
21.3M
Open
Day range
Prev close
Volume
IPO date
Feb 16, 1996

Iridex Corp (IRIX) Stock Price

  • Reported a net loss of $4.4M in FY2026.
  • Revenue grew 34% from FY2020 to FY2024.
  • Trading 43% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review IRIDEX CORP.

Write a review
Newsroom

News about IRIDEX CORP

News & sentiment via Polygon.io

FAQ

Iridex Corp: frequently asked questions

Is Iridex Corp an American company?

Iridex Corp is a US-based company headquartered in Mountain View, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Iridex Corp headquartered?

Iridex Corp is headquartered in Mountain View, California, United States.

Is Iridex Corp publicly traded?

Yes — Iridex Corp is a publicly traded company. Its stock trades under the ticker symbol IRIX on the NASDAQ.

What does Iridex Corp do?

Iridex Corp is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →